A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lungLo M. Sosinski, Robert A. Quinn, Lydia-Ann J. Ghuneim et al.|Journal of Cystic Fibrosis|2021Cited by 71